|
Erminio "Mimo" Costa (1924, Cagliari, Italy - 2009, Washington, D.C., USA) was a neuroscientist. His research interests covered brain serotonergic activity in health and disease, benzodiazepine-GABA interactions, benzodiazepine action at GABAA receptors, and GABAergic dysfunction and changes in the expression of reelin and GAD67 in schizophrenia. He published more than 1000 articles.〔(【引用サイトリンク】 title=UIC, Dept. of Psychiatry News: Erminio Costa, M.D., Logs 1,000th Publication )〕 The June 2011 issue of the journal ''Neuropharmacology'' was dedicated to him. ==Career== *July, 1947 - M.D. 110/110 cum laude, University of Cagliari, Italy *1950-1960 - Thudichum Psychiatric Research Laboratory, Galesburg Research Hospital, Galesburg, Illinois *1960-1965 - Deputy Chief, Laboratory of Chemical Pharmacology at NHLI - NIH, Bethesda, Maryland *1965-1968 - Associate Professor of Pharmacology and Neurology, College of Physicians and Surgeons of Columbia University, New York, NY *1968-1985 - Chief of the Laboratory of Preclinical Pharmacology, NIMH, St. Elizabeths Hospital, Washington, DC *1985-1994 - Director and Founder, Institute of Neuroscience, and Professor of Pharmacology, Georgetown University, Washington, DC *1994-1995 - Director, Center for Neuropharmacology, Nathan Kline Institute for Psychiatric Research, New York University, New York, NY *1995 - Scientific Director, Psychiatric Institute, Professor of Biochemistry in Psychiatry, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, Chicago, Illinois *1982 - Member, National Academy of Sciences *1991 - Member of "Accademia dei Lincei" founded by Galileo Galilei in 1602, Rome 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Erminio Costa」の詳細全文を読む スポンサード リンク
|